• SENSEX 81,425.15
    323.83 (+0.40%)
  • BANKNIFTY 54,536.00
    319.90 (+0.59%)
  • N S D L
    1,301.00 880.00(%)
  • Vikram Solar
    407.85 381.70(%)
  • Kotak Mah. Bank
    1,990.00 2,301.55(%)
  • Avanti Feeds
    767.45 965.00(%)
  • Waaree Energies
    3,501.00 3,740.75(%)
  • MIC Electronics
    78.02 114.74(%)
  • Netweb Technol.
    3,217.95 3,312.00(%)
  • Bharat Electron
    389.00 435.95(%)
  • ICICI Bank
    1,416.35 1,494.10(%)
  • Timken India
    3,030.00 3,955.10(%)
  • TCS
    3,122.00 4,548.00(%)
  • Maruti Suzuki
    15,077.60 10,725.00(%)
  • Oracle Fin.Serv.
    9,299.00 13,203.60(%)
  • One Mobikwik
    299.35 218.85(%)
  • Infosys
    1,534.50 2,006.80(%)
  • Mamata Machinery
    492.00 649.00(%)
  • Vodafone Idea
    7.50 13.75(%)
  • M & M
    3,592.15 2,360.45(%)
  • Reliance Industr
    1,388.65 1,551.00(%)
  • Welspun Living
    128.25 188.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kopran Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Parijat
  • BSE Code : 2717.0
  • ISIN : INE082A01010
182.72 -2 (-1.10%)
  • As on 10 Sep 2025 (EOD)

  • Today’s Low

    181.10

  • Today’s High

    186.90

  • Open

    185.00

  • Perv Close

    184.76

  • 52W Low

    154.06

  • 52W High

    369.70

Key Indicators

  • P/E(TTM)

    34.11

  • Mar.Cap (₹Cr.)

    892.12

  • Div & Yield %

    1.63

  • Book Value(₹)

    89.35

  • Debt-Equity Ratio

    -1.10

  • AGM Date

    10-Sep-2025

  • EPS

    5.41

  • P/E Ratio

    34.11

Financials Ratios

  • Debt-Equity Ratio

    0.19

  • Mar.Cap (₹Cr.)

    892.12

  • RONW (%)

    10.95

  • ROCE (%)

    13.57

Score Board

  • Equity (₹ in Cr.)

    48.29

  • BV (₹)

    89.40

  • Sales( ₹ in Cr.)

    271.01

  • NP (in Cr.)

    26.86

  • NP Var(%)

    -22.0

  • Div%

    30.0

  • CPS (₹)

    6.60

  • EPS (₹)

    5.60

  • Traded Value (₹ in Lakhs)

    891.11

  • 52 Week High

    369.70

  • 52 Week Low

    154.06

  • Price BSE

    185.0

  • Price NSE

    185.00

  • Market Capital( in Cr.)

    891.11

  • P/C Ratio

    28.00

  • P/E Ratio

    33.30

  • Price Vs.BV

    5.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 271.01 337.46 273.09 204.52 222.83 179.29
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 271.01 337.46 273.09 204.52 222.83 179.29
Other Income 5.90 16.71 16.09 8.03 10.41 1.99
Stock Adjustments 1.84 1.74 -3.55 3.93 -14.70 17.33
Total Income 278.75 355.91 285.63 216.48 218.54 198.61
EXPENDITURE :            
Raw Materials 159.22 231.89 174.14 131.75 123.04 118.50
Power and Fuel Cost 8.59 7.89 7.58 6.51 5.68 6.21
Employee Cost 30.02 25.61 25.15 21.05 18.34 20.02
Other Manufacturing Expenses 12.56 12.45 10.69 9.75 8.33 7.28
Selling and Administration Expenses 21.35 22.45 20.85 22.65 19.79 19.54
Miscellaneous Expenses 2.46 1.98 3.23 1.31 2.75 1.90
Employee Benefit Expenses 30.02 25.61 25.15 21.05 18.34 20.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 234.19 302.26 241.63 193.03 177.93 173.45
Operating Profit 44.56 53.64 44.00 23.44 40.62 25.16
Interest 3.77 4.50 2.67 2.95 3.81 5.96
Gross Profit 40.79 49.14 41.33 20.49 36.81 19.20
Depreciation 5.00 4.62 4.41 4.32 4.10 3.47
Profit Before Tax 35.79 44.52 36.92 16.17 32.71 15.73
Current Tax 8.63 10.08 5.87 3.75 5.76 2.80
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.31 -0.20 -0.21 0.67 3.48 1.71
Reported Net Profit 26.86 34.64 31.25 11.74 23.47 11.22
Extraordinary Items 0.00 -0.01 0.00 0.00 -0.01 -0.04
Adjusted Net Profit 26.86 34.65 31.25 11.74 23.48 11.26
Adjustment below Net Profit 0.06 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 99.38 79.20 62.41 57.15 40.17 28.95
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 14.46 14.46 14.46 6.49 6.49 0.00
P & L Balance carried down 111.83 99.38 79.20 62.41 57.15 40.17
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 30.00 30.00 30.00 30.00 0.00
Dividend Per Share(Rs) 3.00 3.00 3.00 3.00 3.00 0.00
Earnings Per Share-Unit Curr 5.56 7.18 6.48 2.44 5.43 2.59
Earnings Per Share(Adj)-Unit Curr 5.56 7.18 6.48 2.44 5.43 2.59
Book Value 89.35 86.47 82.05 78.56 57.07 53.10
Book Value(Adj)-Unit Curr 89.35 86.47 82.05 78.56 57.07 53.10

Shareholding Pattern

  • Promoter Group

    44.42%

  • Public Share Holding

    55.58%

  • Custodian

    0.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 17,795,993 36.86 17,795,993 6
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,653,210 7.57 3,653,210 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 21,449,203 44.42 21,449,203 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 600 0.00 300 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 364,701 0.76 364,701 26
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 300 0.00 0 3
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,511 0.00 1,011 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 367,112 0.76 366,012 38
2] Non Institution
Bodies Corporate 2,835,946 5.87 2,816,346 325
Clearing Members 61,329 0.13 61,329 23
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,628,212 3.37 1,628,062 911
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,259,076 2.61 1,259,076 1,306
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,683,993 7.63 3,683,993 64
Individuals holding nominal share capital up to Rs. 1 lakh 16,996,786 35.20 16,758,263 57,506
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,948 0.00 1,948 2
Others 1,500 0.00 1,500 1
Sub Total 26,468,790 54.82 26,210,517 60,138
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 500 0.00 500 1
Total Shares held by Custodians and against which Depository Receipts have been issued 500 0.00 500 1
Grand Total ( A + B + C ) 48,285,605 100.00 48,026,232 60,194

Company Background

Kopran LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Kopran Ltd
  • BSE Code : 2717.0
  • ISIN : INE082A01010

  • Incorporation Year

    1958

  • Registered Office

    Parijat House 1076
    Dr E Moses Road Worli, Mumbai,
    Maharashtra-400018

  • Telephone

    91-22-43661111

  • FAX

    91-22-24950363

  • Chairman

    Susheel Somani

  • Managing Director

  • Company Secretary

    Sunil Sodhani

  • Auditor

    Khandelwal Jain & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Kopran Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kopran 184.55 276.91 271.01 34.11 8.54
Abbott India 30,642.75 6,684.73 6,409.15 44.84 44.95
Astrazeneca Phar 9,105.75 1,756.92 1,716.29 124.16 32.94
P & G Health Ltd 6,467.70 944.52 934.17 35.72 40.23
Glaxosmi. Pharma 2,818.30 3,866.05 3,723.49 50.68 58.72
Cipla 1,551.85 20,029.57 19,044.85 23.19 21.40
Amrutanjan Healt 757.65 469.50 451.82 40.17 21.89
Guj. Themis Bio. 381.40 152.47 150.80 93.25 27.21
Fermenta Biotec. 356.80 442.21 430.53 11.84 17.61
Bliss GVS Pharma 153.65 703.42 667.20 22.97 9.16
Ambalal Sarabhai 31.84 19.33 4.04 16.67 2.10